141 related articles for article (PubMed ID: 29883561)
1. Vincristine-Loaded and sgc8-Modified Liposome as a Potential Targeted Drug Delivery System for Treating Acute Lymphoblastic Leukemia.
Duan S; Yu Y; Lai C; Wang D; Wang Y; Xue D; Hu Z; Lu X
J Biomed Nanotechnol; 2018 May; 14(5):910-921. PubMed ID: 29883561
[TBL] [Abstract][Full Text] [Related]
2. Vincristine sulfate liposomal injection for acute lymphoblastic leukemia.
Raj TA; Smith AM; Moore AS
Int J Nanomedicine; 2013; 8():4361-9. PubMed ID: 24232122
[TBL] [Abstract][Full Text] [Related]
3. Sgc8 aptamer targeted glutathione-responsive nanoassemblies containing Ara-C prodrug for the treatment of acute lymphoblastic leukemia.
Fang Z; Wang X; Sun Y; Fan R; Liu Z; Guo R; Xie D
Nanoscale; 2019 Dec; 11(47):23000-23012. PubMed ID: 31769777
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of vincristine sulfate liposome injection (VSLI) in adults with acute lymphoblastic leukemia.
Silverman JA; Reynolds L; Deitcher SR
J Clin Pharmacol; 2013 Nov; 53(11):1139-45. PubMed ID: 23907766
[TBL] [Abstract][Full Text] [Related]
5. Identification of small molecules that mitigate vincristine-induced neurotoxicity while sensitizing leukemia cells to vincristine.
Diouf B; Wing C; Panetta JC; Eddins D; Lin W; Yang W; Fan Y; Pei D; Cheng C; Delaney SM; Zhang W; Bonten EJ; Crews KR; Paugh SW; Li L; Freeman BB; Autry RJ; Beard JA; Ferguson DC; Janke LJ; Ness KK; Chen T; Zakharenko SS; Jeha S; Pui CH; Relling MV; Eileen Dolan M; Evans WE
Clin Transl Sci; 2021 Jul; 14(4):1490-1504. PubMed ID: 33742760
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Vincristine Sulfate Liposome Injection in the Treatment of Adult Acute Lymphocytic Leukemia.
Douer D
Oncologist; 2016 Jul; 21(7):840-7. PubMed ID: 27328933
[TBL] [Abstract][Full Text] [Related]
7. Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein.
Haber M; Norris MD; Kavallaris M; Bell DR; Davey RA; White L; Stewart BW
Cancer Res; 1989 Oct; 49(19):5281-7. PubMed ID: 2569932
[TBL] [Abstract][Full Text] [Related]
8. An Efficient Cell-Targeting Drug Delivery System Based on Aptamer-Modified Mesoporous Silica Nanoparticles.
Yang Y; Zhao W; Tan W; Lai Z; Fang D; Jiang L; Zuo C; Yang N; Lai Y
Nanoscale Res Lett; 2019 Dec; 14(1):390. PubMed ID: 31872318
[TBL] [Abstract][Full Text] [Related]
9. Vincristine-induced neuropathy in pediatric patients with acute lymphoblastic leukemia in Oman: Frequent autonomic and more severe cranial nerve involvement.
Nazir HF; AlFutaisi A; Zacharia M; Elshinawy M; Mevada ST; Alrawas A; Khater D; Jaju D; Wali Y
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28623857
[TBL] [Abstract][Full Text] [Related]
10. Targeted killing of cancer cells in vivo and in vitro with IGF-IR antibody-directed carbon nanohorns based drug delivery.
Li N; Zhao Q; Shu C; Ma X; Li R; Shen H; Zhong W
Int J Pharm; 2015 Jan; 478(2):644-54. PubMed ID: 25510600
[TBL] [Abstract][Full Text] [Related]
11. Vincristine-Induced Peripheral Neuropathy in Childhood Acute Lymphoblastic Leukemia: Genetic Variation as a Potential Risk Factor.
Yang QY; Hu YH; Guo HL; Xia Y; Zhang Y; Fang WR; Li YM; Xu J; Chen F; Wang YR; Wang TF
Front Pharmacol; 2021; 12():771487. PubMed ID: 34955843
[TBL] [Abstract][Full Text] [Related]
12. Proactive therapeutic drug monitoring of vincristine in pediatric and adult cancer patients: current supporting evidence and future efforts.
Wu CY; Li GT; Chu CC; Guo HL; Fang WR; Li T; Wang YR; Xu J; Hu YH; Zhou L; Chen F
Arch Toxicol; 2023 Feb; 97(2):377-392. PubMed ID: 36418572
[TBL] [Abstract][Full Text] [Related]
13.
Keenan B; Finol-Urdaneta RK; Hope A; Bremner JB; Kavallaris M; Lucena-Agell D; Oliva MÁ; Díaz JF; Vine KL
Cancer Cell Int; 2020; 20():170. PubMed ID: 32467666
[TBL] [Abstract][Full Text] [Related]
14. Thermo-Sensitive Liposome co-Loaded of Vincristine and Doxorubicin Based on Their Similar Physicochemical Properties had Synergism on Tumor Treatment.
Li M; Li Z; Yang Y; Wang Z; Yang Z; Li B; Xie X; Song J; Zhang H; Li Y; Gao G; Yang J; Mei X; Gong W
Pharm Res; 2016 Aug; 33(8):1881-98. PubMed ID: 27075873
[TBL] [Abstract][Full Text] [Related]
15. The effect of increased lipoproteins levels on the disposition of vincristine in rat.
Khalil HA; Belal TS; El-Yazbi AF; Hamdy DA
Lipids Health Dis; 2016 Sep; 15(1):152. PubMed ID: 27613245
[TBL] [Abstract][Full Text] [Related]
16. Vincristine-induced paralytic ileus during induction therapy of treatment protocols for acute lymphoblastic leukemia in adult patients.
Yasu T; Ohno N; Kawamata T; Kurokawa Y
Int J Clin Pharmacol Ther; 2016 Jun; 54(6):471-3. PubMed ID: 27087157
[TBL] [Abstract][Full Text] [Related]
17. Co-delivery of vincristine and quercetin by nanocarriers for lymphoma combination chemotherapy.
Zhu B; Yu L; Yue Q
Biomed Pharmacother; 2017 Jul; 91():287-294. PubMed ID: 28463792
[TBL] [Abstract][Full Text] [Related]
18. Successful alternative treatment containing vindesine for acute lymphoblastic leukemia with Charcot-Marie-Tooth disease.
Ichikawa M; Suzuki D; Inamoto J; Ohshima J; Cho Y; Saitoh S; Kaneda M; Iguchi A; Ariga T
J Pediatr Hematol Oncol; 2012 Apr; 34(3):239-41. PubMed ID: 22246157
[TBL] [Abstract][Full Text] [Related]
19. [Release profile of compound liposomes entrapped with vincristine sulfate and mitoxantrone chlorhydric acid in vitro and their distribution in mice].
Chen T; Hou SX; Wang YY; Zhang WS; Chen DH
Yao Xue Xue Bao; 2006 Dec; 41(12):1170-5. PubMed ID: 17290615
[TBL] [Abstract][Full Text] [Related]
20. N1-guanyl-1,7-diaminoheptane enhances the chemosensitivity of acute lymphoblastic leukemia cells to vincristine through inhibition of eif5a-2 activation.
Liu Y; Xue F; Zhang Y; Lei P; Wang Z; Zhu Z; Sun K
Anticancer Drugs; 2017 Nov; 28(10):1097-1105. PubMed ID: 28885268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]